Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Renal Response Criteria for Clinical Trials in Amyloid Light Chain Amyloidosis

Kidney International Reports(2024)10.1016/j.ekir.2024.03.033Source: DataRank Database

Renal Response Criteria for Clinical Trials in Amyloid Light Chain Amyloidosis is a research paper published in Kidney International Reports (2024). On theSindex it has a DataRank of 0. It has been cited 4 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access4 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 0.78)OA: goldTopics (27)IDs (PubMed, PMC, OpenAlex)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (12)

Raymond L. Comenzo ORCID,Julian D. Gillmore ORCID,Andrea Havasi ORCID,Efstathios Kastritis ORCID,Spencer Guthrie ORCID

Live enrichment

PubMed:39081759 PMC:PMC11284377 OpenAlex:https://openalex.org/W4393930379

National Institute on Aging

Grant: R13AG071150

National Institutes of Health

Grant: 1R13AG071150-01

Advancing Drug Development in AL Amyloidosis: Capitalizing Natural History and Assessing Endpoints

GlaxoSmithKline

National Institutes of Health

Australian Research Council

FWCI

0.78

Citation Percentile

0.7%

Citation Trend

2024

2025

2026

goldLicense: cc-by-nc-nd

journalhttps://doi.org/10.1016/j.ekir.2024.03.033

publisherhttps://doi.org/10.1016/j.ekir.2024.03.033

publisherhttps://api.elsevier.com/content/article/PII:S2468024924016206?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2468024924016206?httpAccept=text/plain

repositoryhttps://pubmed.ncbi.nlm.nih.gov/39081759

Fields of Study

Amyloidosis: Diagnosis, Treatment, OutcomesParathyroid Disorders and TreatmentsDrug Transport and Resistance Mechanisms0303 health sciences03 medical and health sciences

Keywords

MedicineAmyloidosisClinical trialContext (archaeology)Renal functionProteinuriaIntensive care medicineAmyloid (mycology)Internal medicinePopulationAL amyloidosisKidneyPathologyImmunologyImmunoglobulin light chainAntibodyRare DiseasesEstimated Glomerular Filtration RateRenal End PointsRC870-923ReviewDiseases of the genitourinary system. Urology